bioRxivSystems BiologyPreprint
WDR88, CCDC11, and ARPP21 genes indulge profoundly in the desmoplastic retort to prostate and breast cancer metastasis.
Abstract
Abstract.Microarray technology has unlocked doors to a multitude of open analysis problems that if conceived with efficacy may uncover varied genotypic and phenotypic traits. Algorithms belonging to different cultures in computer science have been applied to gene expression data to derive correlation and stratification parameters. While most outcomes are subject to clinical validation, majority of which get declined, the search for the precisely targeted therapeutic agents is still on. This paper is an effort in the similar direction and strives to delineate genes with significant stromal signatures. We suggest a corroborative indulgence of a human laterality disorder gene, CCDC11 in the metastasis, in addition to the role of WDR88 and ARPP21 genes has been further materialized in the analysis. Another standout aspect of the study has been the associated implications of the genes in rare disorders of male breast and female prostate cancers. There is also a threshold proposal that stratifies \"safe\" expression space for genes. Complimentarily, the manuscript serves as an expedient protocol for anyone seeking microarray data analysis, particularly in R.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: benchmarking
- approach: statistical model
- Citations
- 5
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Gene Expression Profiles Reveal Potential Targets for Breast Cancer Diagnosis and Treatment
M. H. Nasirpour, M. Sabery Anvar, … Z. Minuchehr·bioRxiv·Sep 3, 2022
- A Tumor Suppressor-Regulated Cell Cycle Derived Gene Signature Is Prognostic Of Recurrence Risk In Prostate Cancer
C. Georgescu, J. M. Corbin, … M. J. Ruiz Echevarria·bioRxiv·Aug 21, 2018
- Transcription factor 19 is an androgen responsive gene that modulates vessel homeostasis and sustains metastatic prostate cancer
Amaia Ercilla, Jana R. Crespo, … Arkaitz Carracedo·bioRxiv·Feb 4, 2025
- Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypes
A. K. Bajpai, S. Davuluri, … K. K. Acharya·bioRxiv·Aug 4, 2021
- The cornerstone of early diagnosis and immunotherapy of prostate cancer:screening characteristic genes
Bo Shao, Kaixiu Wu, … Zhongxiong Han·bioRxiv·May 15, 2024
- Deep Genomic Signature for early metastasis prediction in prostate cancer
Hossein Sharifi-Noghabi, Yang Liu, … Martin Ester·bioRxiv·Feb 19, 2019